Inventor · disambiguated record
Norbert Handler
Also filed as: HANDLER NORBERT
9 granted patents·10 pending applications·6 citations·filing 2004–2019
78Inventor score
Files withSAVIRA PHARMACEUTICALS GMBH10HOFFMANN LA ROCHE7RD&C RES DEVELOPMENT & CONSULTING GMBH1SZEKERES THOMAS1
Top patents by PatentIndex Score
19 records- 0178US9827244B2Cap/endo dual inhibitors and their use in the treatment, amelioration or prevention of a viral diseaseHOFFMANN LA ROCHE·Filed 2016·Granted Nov 28, 2017·3 cites·20 claims
- 0270US8921388B2Dihydroxypyrimidine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral diseaseSAVIRA PHARMACEUTICALS GMBH·Filed 2013·Granted Dec 30, 2014·2 cites·28 claims
- 0363US9434745B27-oxo-thiazolopyridine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral diseaseSAVIRA PHARMACEUTICALS GMBH·Filed 2013·Granted Sep 6, 2016·1 cites·14 claims
- 0462US9199987B2Substituted naphthyridines for the treatment, amelioration or prevention of a viral diseaseSAVIRA PHARMACEUTICALS GMBH·Filed 2014·Granted Dec 1, 2015·0 cites·8 claims
- 0558US9505758B2Substituted 1,5-naphthyridines as endonuclease inhibitorsSAVIRA PHARMACEUTICALS GMBH·Filed 2015·Granted Nov 29, 2016·0 cites·5 claims
- 0655US2017290834A1Naphthyridinone derivatives and their use in the treatment, amelioration or prevention of a viral diseaseSAVIRA PHARMACEUTICALS GMBH·Filed 2016·Application pending·0 cites
- 0748US9359351B2Cap/endo dual inhibitors and their use in the treatment, amelioration or prevention of a viral diseaseHOFFMANN LA ROCHE·Filed 2015·Granted Jun 7, 2016·0 cites·19 claims
- 0847US2016362423A17-oxo-thiazolopyridine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral diseaseSAVIRA PHARMACEUTICALS GMBH·Filed 2016·Application pending·0 cites
- 0943US12186740B2Kits comprising containers with at least one solid catalytically active compound, and their uses in solid state reactionRD&C RES DEVELOPMENT & CONSULTING GMBH·Filed 2019·Granted Jan 7, 2025·0 cites·14 claims
- 1043US8952039B2Pyridone derivatives and their use in the treatment, ameloriation or prevention of a viral diseaseSAVIRA PHARMACEUTICALS GMBH·Filed 2014·Granted Feb 10, 2015·0 cites·13 claims
- 1143US2013317021A1Heterocyclic pyrimidine carbonic acid derivatives which are useful in the treatment, amelioration or prevention of a viral diseaseSAVIRA PHARMACEUTICALS GMBH·Filed 2013·Application pending·0 cites
- 1242US9045486B2Pyrimidone derivatives and their use in the treatment, amelioration or prevention of a viral diseaseSAVIRA PHARMACEUTICALS GMBH·Filed 2014·Granted Jun 2, 2015·0 cites·13 claims
- 1341US2017081323A1Triazolones derivatives for use in the treatment, amelioration or prevention of a viral diseaseHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 1441US2017081331A1Pyrazolopyrazines and their use in the treatment, amelioration or prevention of a viral diseaseHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 1538US2016367557A1Heterocyclic pyrimidine carbonic acid derivatives which are useful in the treatment, amelioration or prevention of a viral diseaseSAVIRA PHARMACEUTICALS GMBH·Filed 2016·Application pending·0 cites
- 1636US2017100396A1Pyrrolopyrazine derivatives for use in the treatment, amelioration or prevention of influenzaHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 1735US2017081324A1Triazolones derivatives and their use in the treatment, amelioration or prevention of a viral diseaseHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 1832US2016002226A1Pyridopyrazine compounds and their use in the treatment, amelioration or prevention of influenzaHOFFMANN LA ROCHE·Filed 2015·Application pending·0 cites
- 1929US2007191627A1Stilbene derivatives and their use in medicamentsSZEKERES THOMAS·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Norbert Handler files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →